Trial Profile
A multicentre randomized double-blind placebo controlled discontinuation trial of methylphenidate
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 May 2019
Price :
$35
*
At a glance
- Drugs Methylphenidate (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- Acronyms MASK
- 12 May 2019 Status changed to completed as per results published in the American Journal of Psychiatry
- 12 May 2019 Results published in the American Journal of Psychiatry
- 15 Jul 2015 New trial record